Propeller Bio is founded by David Shen along with a group of seasoned biotech entrepreneurs with a proven track record of success. Supported by leading investors, the company focuses on discovering and developing innovative biologic therapeutics designed to safely and effectively target multiple disease-driving pathways, aiming for synergistic effects to treat patients with unmet medical needs. The organization boasts a diverse team with extensive expertise in drug discovery and development, and is based in the Bay Area, California.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.